

TUESDAY LAB AGENDA
Seating is limited - sign up today!
LABS LOCATION
Ulmer & Berne LLP
500 W. Madison, Ste. 3600
Chicago, IL 60661-4587
BD TRACK ---> 9:00am 10:30am
LAB BD: Testing/Risk Assessment
• Coming up with a game plan including resources and technology
• How to do a risk assessment
• Sampling - what to pick and how many
• Case study - actually conducting a review
• Reporting the findings and doing the follow-up
James Downing, Cheevers & Company, Inc.
Matt Dwyer, MCD Consulting
BD TRACK ---> 10:45am 12:15pm
LAB BD: Advertising/ Marketing/Social Media
• The who, what, when, where, why & how approach to advertising and marketing review
• Learn the three most important rules for communications with the public
• Social media... friend or foe? What you need to know to keep your firm compliant
• What to do when you receive a FINRA comment letter
• Advertising/marketing review - 80% logic, 20% rules
Brandon L. Klerk, Incapital, LLC
Christopher P.
Parrington, Skjold-Barthel, P.A.
BD TRACK ---> 1:30pm 3:00pm
LAB BD: How to Conduct a Branch Exam
• What do I need to know before I go in? Background work
• What do I cover in the first hour on-site?
• Writing the report - what goes in, what stays out
• You mean I have to follow up?
• Life cycle of a branch audit
Jerry C. Danielson, Lincoln Financial Group
IA Track ---> 9:00am 10:30am
LAB IA/HF: Writing an ADV
• An overview of the brochure rule and regulatory requirements
• Part 2 components and examples of common errors
• Understanding SEC disclosure expectations and your disclosure responsibilities
• Does it align with your offering documents and marketing materials?
• Exercise on the writing of an ADV
Uzi Rosha, CarVal Investors
James Martignon, Ulmer & Berne LLP
IA Track ---> 10:45am 12:15pm
LAB IA/HF: Testing/Risk Assessment
• Coming up with a game plan including resources and technology
• How to do a risk assessment
• Sampling - what to pick and how many
• Case study - actually conducting a review
• Reporting the findings and doing the follow-up
Lisa L. Tharpe, Foley & Lardner LLP
Pamela K. Ziermann, Dougherty Financial Group LLC
IA Track ---> 1:30pm 3:00pm
LAB IA/HF: Managing Conflicts of Interest (Fiduciary Duty)
• Establishing an effective code of ethics, robust procedures and effective oversight
• Managing potential confidentiality and insider issues
• Side by side management of funds/client assets
• Valuation and performance oversight
• Side letters and other conflicts of interest
Laura J. Rauman, Vista360, LLC
Jennifer D. Lammers, Fiduciary Counselling, Inc.
MONDAY MEETING AGENDA
MEETING LOCATION
Gleacher Center
450 N. Cityfront Plaza Drive
Chicago, IL 60611
GENERAL SESSION ---> 8:30am 10:00am
DIALOGUE WITH AREA REGULATORS
• Changes in the regulatory landscape: new rules and focuses
• Exam priorities, deficiencies, and enforcement
• Internal controls for compliance officers to consider
David H. Lui, Galliard Capital Management
Peter B. Driscoll, U.S. Securities & Exchange Commission
Laura Trotz, FINRA
Session I ---> 10:15am 11:30am
I(a) BD Compliance and Risk in Todays World
• What is compliances role in risk management?
• How to identify key risks in an ever-changing business and regulatory environment
• Developing programs to address identified risks
• Communicating the firms risk management process to regulators and clients/consultants
Mark T. Carberry, Schuyler, Roche & Crisham, P.C.
Kenneth Cherrier, Waddell & Reed
I(b) IA/HF Compliance and Risk in Todays World
• What is compliances role in risk management?
• How to identify key risks in an ever-changing business and regulatory environment
• Developing programs to address identified risks
• Communicating the firms risk management process to regulators and clients/consultants
Jeffrey Blumberg, Drinker Biddle & Reath LLP
Joseph M. Mannon, Aurora Investment Management L.L.C.
Steven Farmer, Mesirow Advanced Strategies, Inc.
I(c) IA/HF Introduction to compliance
• Requirements for a compliance program
• The Role of a Compliance Officer in a newly regulated entity
• Developing (or establishing) a Culture of Compliance
• Managing credibility; how to say no yet still advocate your firms initiatives
• How to use risk and conflict of interest assessments to enhance the compliance function
Steven G. Lentz, Faegre & Benson LLP
J. Christopher Jackson, Calamos Investments
Session II ---> 12:45pm 2:00pm
II(a) GI Best Practices: Current Hot Products
• A review of the current hot products
• The regulators perspective on these products
• Best practices for evaluating and vetting these products
• Surveillance techniques and the regulators view on these products
• Use of disclosure to avoid complaints and litigation
David Rosedahl, Briggs & Morgan
David E. Fischer-Lodike, Edward Jones Investments
II(b) GI Best Practices: Compliance with Retirement Issues
• Recent updates to ERISA (fee disclosure and participant advice)
• Applicability of IRC 4975 to IRA Beneficiaries
• Issues with annuities, target date funds, and stable value funds
• Sales practice issues (senior suitability, retirement income planning)
Robert Toth, Law Offices of Robert J. Toth, Jr. LLC
Christopher M. Guanciale, PlanMember Services Corporation
II(c) GI Best Practices: Avoiding Litigation and Managing Publicity for Compliance Officers
• How to identify problematic issues before they turn into an enforcement action or litigation
• Proactive steps to protect the firm and its stakeholders once a problem arises
• A compliance officers guide to avoid being the subject of a failure to supervise claim
• How do you respond or advise management when the press calls about a problem?
David Porteous, Ulmer & Berne LLP
A. Brad Busscher, Incapital Holdings LLC
Session III ---> 2:15pm 3:30pm
III(a) BD Examinations Process (Internal and External)
• Preparation and management of the regulatory exam process
• Conducting your internal review and identifying hot topics
• The relationship between the internal and external reviews
• How to identify and address the hot topics for the external and internal reviews
• Addressing the exam deficiencies
Alan M. Wolper, Locke Lord Bissell & Liddell LLP
Wesley L. Ringo, J.J.B. Hilliard, W.L. Lyons, LLC
III(b) IA Examinations Process (Internal and external)
• Preparation and management of the regulatory exam process
• Conducting your internal review
• The relationship between the internal and external reviews
• Addressing the exam deficiencies and identifying hot topics
Michael Wise, Lawrence, Saunders & Uhlenhop, L.L.C.
Mary Keefe, Nuveen Investments
III(c) HF Examinations Process (Internal and External)
• Compliance framework and conducting internal review or testing
• Identifying internal hot topics subject to external regulatory review
• Preparation and management of the regulatory exam process
• Deficiency Letter versus Enforcement and resolving deficiencies
Jeffrey M. Squires, Vista360, LLC
Katie S. Kloster, Värde Partners, Inc.
Session IV ---> 3:45pm 5:00pm
IV(a) BD Ethics - Code of Conduct
• ABA & State Bar requirements for attorneys to report
• SEC requirements for self reporting
• Practical tips for creation, distribution, and analysis
• Use in litigation and investigations
• What you say or dont say can and will be used against you
Allan Horwich, Schiff Hardin LLP
Jeffrey Suhanic, PNC
IV(b) IA/HF Code of Ethics
• Defining the parameters, duties, responsibilities/liabilities and enforcement
• Build it, expand it, maintain it (policies and procedures) and test it
• Risks and conflicts of interest internal and beyond
• Personal trading policies and procedures
James Martignon, Ulmer & Berne LLP
IV(c) IA/HF Recordkeeping
• Developing an effective recordkeeping program critical elements to consider
• Practical solutions for maintaining records and application to IA books andrecords requirements
• Data information security and other issues to consider for electronic maintenance
• How litigation attorneys and the SEC apply procedural rules to investment advisers
Joseph D. McDermott, Alaric Compliance Services, LLC